In addition to General Cardiology and Echocardiography, Asst. Prof. Tan's other specialty interest includes Cardio-Oncology for which she was awarded the Healthcare Manpower Development Plan (HMDP) and underwent advanced fellowship training at the Royal Brompton Hospital (London, UK) with aims to improve the heart health of cancer patients and survivors. She is currently serving as the Clinical Lead of Cardio-oncology Service, Department of Cardiology, NUHCS.

Asst. Prof. Tan is also active in medical education and clinical research. She holds the appointment of Assistant Professor with the Yong Loo Lin School of Medicine, NUS, and is a core faculty member of the NUHCS Cardiology Senior Residency Program.

1. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Lyon AR, Dent S, Stanway S, Earl H, Brezden-Masley C, Cohen-Solal A, Tocchetti CG, Moslehi JJ, Groarke JD, Bergler-Klein J, Khoo V, Tan LL, Anker MS, von Haehling S, Maack C, Pudil R, Barac A, Thavendiranathan P, Ky B, Neilan TG, Belenkov Y, Rosen SD, Iakobishvili Z, Sverdlov AL, Hajjar LA, Macedo AVS, Manisty C, Ciardiello F, Farmakis D, de Boer RA, Skouri H, Suter TM, Cardinale D, Witteles RM, Fradley MG, Herrmann J, Cornell RF, Wechelaker A, Mauro MJ, Milojkovic D, de Lavallade H, Ruschitzka F, Coats AJS, Seferovic PM, Chioncel O, Thum T, Bauersachs J, Andres MS, Wright DJ, López-Fernández T, Plummer C, Lenihan D. Eur J Heart Fail. 2020 Nov;22(11):1945-1960. doi: 10.1002/ejhf.1920. Epub 2020 Aug 6.PMID: 32463967 

2. Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study. Lee PY, Oen KQX, Lim GRS, Hartono JL, Muthiah M, Huang DQ, Teo FSW, Li AY, Mak A, Chandran NS, Tan CL, Yang P, Tai ES, Ng KWP, Vijayan J, Chan YC, Tan LL, Lee MB, Chua HR, Hong WZ, Yap ES, Lim DK, Yuen YS, Chan YH, Aminkeng F, Wong ASC, Huang Y, Tay SH. Cancers (Basel). 2021 Mar 15;13(6):1308. doi:10.3390/cancers13061308.PMID: 33804050

3. Activity and Outcome of a Cardio-Oncology Service in the United Kingdom – a Five-Year Experience. Nilesh Pareek, Joaquim Cevallos, Pedro Moliner, Mit Shah, Li-Ling Tan, Vicki Chambers, A John Baksi, Rajdeep S Khatter, Rakesh Sharma, Stuart D Rosen, Alexander R. Lyon. Eur J Heart Fail. 2018 Dec;20(12):1721-1731. doi: 10.1002/ejhf.1292. Epub 2018 Sep 6.PMID: 30191649 

4.  Chemotherapy and adverse cardiovascular events in colorectal cancer patients undergoing surgical resection. Koo CY, Tai BC, Chan DKH, Tan LL, Tan KK, Lee CH.World J Surg Oncol. 2021 Jan 21;19(1):21. doi: 10.1186/s12957-021-02125-5.PMID: 33478503 

5. Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment. Tan LL, Lyon AR. Curr Treat Options Cardiovasc Med. 2018 Jun 19;20(7):55. doi: 10.1007/s11936-018-0641-z.PMID: 29923056
6. First Medical Contact-to-Device Time and Heart Failure Outcomes Among Patients Undergoing Primary Percutaneous Coronary Intervention. Loh JP, Tan LL, Zheng H, Lau YH, Chan SP, Tan KB, Chua T, Tan HC, Foo D, Lee CW, Tong KL, Foo LL, Hausenloy D, Sahlen A, Yeo KK, Fox KAA, Wang TY, Richards AM, Chan MY.Circ Cardiovasc Qual Outcomes. 2018 Aug;11(8):e004699. doi: 10.1161/CIRCOUTCOMES.118.004699.PMID: 30354372

7. Mid-regional pro-adrenomedullin outperforms N-terminal pro-B-type natriuretic peptide for the diagnosis of acute heart failure in the presence of atrial fibrillation. Kuan WS, Ibrahim I, Chan SP, Li Z, Liew OW, Frampton C, Troughton R, Pemberton CJ, Chong JPC, Tan LL, Lin W, Ooi SBS, Richards AM. Eur J Heart Fail. 2020 Apr;22(4):692-700. doi: 10.1002/ejhf.1660. Epub 2019 Dec 6.PMID: 31808279

8. Superior performance of N-terminal pro brain natriuretic peptide for diagnosis of acute decompensated heart failure in an Asian compared with a Western setting. Ibrahim I, Kuan WS, Frampton C, Troughton R, Liew OW, Chong JP, Chan SP, Tan LL, Lin WQ, Pemberton CJ, Ooi SB, Richards AM. Eur J Heart Fail. 2017 Feb;19(2):209-217. doi: 10.1002/ejhf.612. Epub 2016 Sep 13.PMID: 27620387

9. Sleep Apnea Evolution and Left Ventricular Recovery After Percutaneous Coronary Intervention for Myocardial Infarction. Tan LL, Ting J, Balakrishnan I, Seneviratna A, Gong L, Chan MY, Tai ES, Richards AM, Tai BC, Ling LH, Lee CH.J Clin Sleep Med. 2018 Oct 15;14(10):1773-1781. doi: 10.5664/jcsm.7394.PMID: 30353816 

10. Watch-PAT versus level III device in diagnosing sleep disordered breathing in first myocardial infarction. Ting J, Tan LL, Balakrishnan ID, Chan SP, Yeo TC, Lee CH.Clin Respir J. 2018 Aug;12(8):2332-2339. doi: 10.1111/crj.12909.PMID: 29729122